Response Genetics, Inc. (RGDX) Posts Q4 Loss of 21c/Share, Wider than Views

March 27, 2012 8:32 AM EDT
Response Genetics, Inc. (NASDAQ: RGDX) reported Q4 EPS of ($0.21), $0.17 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $4.9 million versus the consensus estimate of $5.7 million.

For earnings history and earnings-related data on Response Genetics, Inc. (RGDX) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings